Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Signal sequence receptor, gamma pseudogene (ENSG00000213560) is annotated as a pseudogene within the human genome. Pseudogenes are gene sequences that resemble protein-coding genes but contain mutations (such as frameshifts or premature stop codons) that prevent them from encoding a functional protein product[10][7]. The functional homolog to this pseudogene would be "Signal sequence receptor subunit 3" (SSR3), a protein-coding gene involved as part of the signal sequence receptor complex in protein translocation across the endoplasmic reticulum membrane[1][6]. As a pseudogene, ENSG00000213560 does not produce a functional protein and is not considered a therapeutic target, nor does it have known biological functions or disease roles. Its annotation may cause confusion if used in a therapeutic or functional context, as it should not be referenced as a druggable or biologically active target[10][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Signal sequence receptor, gamma pseudogene.